Page last updated: 2024-12-05

bis(2-chloroethyl)ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bis(2-chloroethyl)ether: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8115
CHEMBL ID1613350
CHEBI ID34573
SCHEMBL ID58439
MeSH IDM0049507

Synonyms (138)

Synonym
BIDD:ER0300
bis-2-chloroethylether
ethane, 1,1'-oxybis[2-chloro-
inchi=1/c4h8cl2o/c5-1-3-7-4-2-6/h1-4h
s-dichloroethyl ether
di(.beta.-chloroethyl) ether
2,2'-dichlorethyl ether
2,2'-dicloroetiletere
chloroethyl ether
2,2'-dichloorethylether
dichloroether
nsc406647
1,1'-oxybis[2-chloroethane]
2,2'-dichlor-diaethylaether
bis(2-chloroethyl) ether
111-44-4
dichloroethyl oxide
khloreks
2,2'-dichlorodiethyl ether
dichlorodiethyl ether
1-chloro-2-(.beta.-chloroethoxy)ethane
dichloroethyl ether
ent 4,504
ether dichlore
oxyde de chlorethyle
bis(chloroethyl) ether
ether, bis(2-chloroethyl)
1,5-dichloro-3-oxapentane
2,2'-dichloroethyl ether
nsc-406647
dcee
chlorex
dwuchlorodwuetylowy eter
.beta.,.beta.'-dichloroethyl ether
sym-dichloroethyl ether
bis(.beta.-chloroethyl) ether
.beta.,.beta.'-dichlorodiethyl ether
bis(chloro-2-ethyl) oxide
clorex
2-chloroethyl ether
wln: g2o2g
di(2-chloroethyl) ether
ethane,1'-oxybis[2-chloro-
bis(2-chloroethyl)ether
NCGC00090856-01
dicholoroethyl ether
beta,beta'-dichloroethyl ether
2,2'-dicloroetiletere [italian]
caswell no. 309
1-chloro-2-(beta-chloroethoxy)ethane
2,2'-dichloorethylether [dutch]
bcee
rcra waste number u025
ethane, 1,1'-oxybis(2-chloro-
epa pesticide chemical code 029501
rcra waste no. u025
beta,beta-dichlorodiethyl ether
brn 0605317
di(beta-chloroethyl)ether
nsc 406647
ai3-04504
2,2'-dichlor-diaethylaether [german]
einecs 203-870-1
dwuchlorodwuetylowy eter [polish]
ccris 88
beta,beta'-dichlorodiethyl ether
bis(chloroethyl)ether
2,2'-dichlorodiethylether
un1916
bis(beta-chloroethyl) ether
ether dichlore [french]
hsdb 502
1-chloro-2-(2-chloroethoxy)ethane
oxyde de chlorethyle [french]
1,1'-oxybis(2-chloro)ethane
1,1'-oxybis(2-chloroethane)
2-chloroethyl ether, 99%
bis(chloroethyl)ether (bcee)
B0472
MLS002454390
smr001372006
bis-(2-chloroethyl)ether
AKOS000118954
NCGC00090856-02
NCGC00090856-03
HMS3039G11
NCGC00254256-01
cas-111-44-4
tox21_300514
dtxcid70168
NCGC00259623-01
tox21_202074
dtxsid9020168 ,
BCP9000069
2-dichlorodiethyl ether
STL282719
unii-6k7d1g5m5n
2,2'-dichlorodiethyl ether [un1916] [poison]
ec 203-870-1
6k7d1g5m5n ,
2-chloro-1-(2-chloroethoxy)ethane
SCHEMBL58439
bis (2-chloroethyl) ether
bis(beta-chloroethyl)ether
bis (2-chloroethyl)ether
1-chloromethylmethyl ether
bis-(2-chloroethyl) ether
bis-(2chloroethyl)ether
1-chloromethylmethylether
2-chloroethylether
1-chloro-2-(2-chloroethoxy) ethane
1-chloro-2-(2-chloro-ethoxy)-ethane
bis-(2-choroethyl)ether
bis(2-chloroethyl) ether [hsdb]
bis(2-chloroethyl)ether [iarc]
sym-dichloroethyl ether [mi]
CHEBI:34573 ,
Q-200159
CHEMBL1613350
diethylene glycol dichloride
ether, bis(chloroethyl)
un 1916
2,2'-dichlorodiethyl oxide
1-chloro-2-(2-chloroethoxy)ethane #
ethane, 1,1'-oxybis[1-chloro-
2,2-dichlorodiethylether
F0001-0241
mfcd00000975
bis(2-chloroethyl) ether, puriss., >=99.0% (gc)
EN300-19202
BCP22801
Q2509768
AS-11884
1-(2-chloroethoxy)-2-chloroethane
AMY9389
bis(2-chloroethyl) ether 1000 microg/ml in methanol
bis(2-chloroethyl) ether 1000 microg/ml in methanol, second source
2,2'-dichlorodiethyl ether, bis(2-chloroethyl) ether
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
etherAn organooxygen compound with formula ROR, where R is not hydrogen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.39810.003245.467312,589.2998AID2517
TDP1 proteinHomo sapiens (human)Potency2.90930.000811.382244.6684AID686978
chromobox protein homolog 1Homo sapiens (human)Potency79.43280.006026.168889.1251AID540317
gemininHomo sapiens (human)Potency0.00730.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (38.10)18.7374
1990's2 (9.52)18.2507
2000's4 (19.05)29.6817
2010's5 (23.81)24.3611
2020's2 (9.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.55 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index60.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]